156 related articles for article (PubMed ID: 30502293)
1. Late Shoulder-Arm Morbidity Using Ultrasound Scalpel in Axillary Dissection for Breast Cancer: A Retrospective Analysis.
Iovino F; Gatta G; Auriemma PP; Dani L; Antoniol G; Barbarisi A
J Surg Res; 2019 Jan; 233():88-95. PubMed ID: 30502293
[TBL] [Abstract][Full Text] [Related]
2. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up on shoulder and arm morbidity in patients treated for early breast cancer.
Hauerslev KR; Madsen AH; Overgaard J; Damsgaard TE; Christiansen P
Acta Oncol; 2020 Jul; 59(7):851-858. PubMed ID: 32285717
[No Abstract] [Full Text] [Related]
4. Preventing seroma formation after axillary dissection for breast cancer: a randomized clinical trial.
Iovino F; Auriemma PP; Ferraraccio F; Antoniol G; Barbarisi A
Am J Surg; 2012 Jun; 203(6):708-14. PubMed ID: 22153087
[TBL] [Abstract][Full Text] [Related]
5. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
[TBL] [Abstract][Full Text] [Related]
6. Arm lymphoedema and upper limb impairments in sentinel node-negative breast cancer patients: A one year follow-up study.
De Groef A; Van Kampen M; Tieto E; Schönweger P; Christiaens MR; Neven P; Geraerts I; Gebruers N; Devoogdt N
Breast; 2016 Oct; 29():102-8. PubMed ID: 27479040
[TBL] [Abstract][Full Text] [Related]
7. Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection--data from a prospective randomised trial.
Helms G; Kühn T; Moser L; Remmel E; Kreienberg R
Eur J Surg Oncol; 2009 Jul; 35(7):696-701. PubMed ID: 18838245
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy and axillary dissection: added morbidity of the arm, shoulder and chest wall after mastectomy and reconstruction.
Sclafani LM; Baron RH
Cancer J; 2008; 14(4):216-22. PubMed ID: 18677128
[TBL] [Abstract][Full Text] [Related]
9. Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer.
Silberman AW; McVay C; Cohen JS; Altura JF; Brackert S; Sarna GP; Palmer D; Ko A; Memsic L
Ann Surg; 2004 Jul; 240(1):1-6. PubMed ID: 15213610
[TBL] [Abstract][Full Text] [Related]
10. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
11. Long-term morbidity after a negative sentinel node in breast cancer patients.
Verbelen H; Tjalma W; Meirte J; Gebruers N
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13077. PubMed ID: 31050088
[TBL] [Abstract][Full Text] [Related]
12. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
13. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Mansel RE; Fallowfield L; Kissin M; Goyal A; Newcombe RG; Dixon JM; Yiangou C; Horgan K; Bundred N; Monypenny I; England D; Sibbering M; Abdullah TI; Barr L; Chetty U; Sinnett DH; Fleissig A; Clarke D; Ell PJ
J Natl Cancer Inst; 2006 May; 98(9):599-609. PubMed ID: 16670385
[TBL] [Abstract][Full Text] [Related]
14. Early and late morbidity associated with axillary levels I-III dissection in breast cancer.
Ernst MF; Voogd AC; Balder W; Klinkenbijl JH; Roukema JA
J Surg Oncol; 2002 Mar; 79(3):151-5; discussion 156. PubMed ID: 11870664
[TBL] [Abstract][Full Text] [Related]
15. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer.
Haid A; Kuehn T; Konstantiniuk P; Köberle-Wührer R; Knauer M; Kreienberg R; Zimmermann G
Eur J Surg Oncol; 2002 Nov; 28(7):705-10. PubMed ID: 12431466
[TBL] [Abstract][Full Text] [Related]
16. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial.
Purushotham AD; Upponi S; Klevesath MB; Bobrow L; Millar K; Myles JP; Duffy SW
J Clin Oncol; 2005 Jul; 23(19):4312-21. PubMed ID: 15994144
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for seroma formation after axillary lymph node dissection with special focus on the impact of early shoulder exercise.
Borg G; Dihge L; Johansson K
Acta Oncol; 2023 May; 62(5):444-450. PubMed ID: 37129993
[TBL] [Abstract][Full Text] [Related]
18. Is it really useful the Harmonic scalpel in axillary dissection for locally advanced breast cancer? A case series.
Militello G; De Marco P; Falco N; Kabhuli K; Mascolino A; Licari L; Tutino R; Cocorullo G; Gulotta G
G Chir; 2016; 37(6):262-265. PubMed ID: 28350973
[TBL] [Abstract][Full Text] [Related]
19. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma.
Schrenk P; Rieger R; Shamiyeh A; Wayand W
Cancer; 2000 Feb; 88(3):608-14. PubMed ID: 10649254
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of harmonic focus scalpel in seroma prevention after axillary clearance.
Selvendran S; Cheluvappa R; Tr Ng VK; Yarrow S; Pang TC; Segara D; Soon P
Int J Surg; 2016 Jun; 30():116-20. PubMed ID: 27142863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
